Literature DB >> 28356515

Identification of targets of tumor suppressor microRNA-34a using a reporter library system.

Yoshiaki Ito1, Atsushi Inoue2, Timothy Seers1,3, Yukari Hato4, Arisa Igarashi2, Tatsuya Toyama4, Konstantin D Taganov5, Mark P Boldin6, Hiroshi Asahara7,2,8,9.   

Abstract

miRNAs play critical roles in various biological processes by targeting specific mRNAs. Current approaches to identifying miRNA targets are insufficient for elucidation of a miRNA regulatory network. Here, we created a cell-based screening system using a luciferase reporter library composed of 4,891 full-length cDNAs, each of which was integrated into the 3' UTR of a luciferase gene. Using this reporter library system, we conducted a screening for targets of miR-34a, a tumor-suppressor miRNA. We identified both previously characterized and previously uncharacterized targets. miR-34a overexpression in MDA-MB-231 breast cancer cells repressed the expression of these previously unrecognized targets. Among these targets, GFRA3 is crucial for MDA-MB-231 cell growth, and its expression correlated with the overall survival of patients with breast cancer. Furthermore, GFRA3 was found to be directly regulated by miR-34a via its coding region. These data show that this system is useful for elucidating miRNA functions and networks.

Entities:  

Keywords:  breast cancer; miR-34a; microRNA target screening; reporter library system

Mesh:

Substances:

Year:  2017        PMID: 28356515      PMCID: PMC5393199          DOI: 10.1073/pnas.1620019114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  65 in total

1.  Transcriptome-wide discovery of microRNA binding sites in human brain.

Authors:  Ryan L Boudreau; Peng Jiang; Brian L Gilmore; Ryan M Spengler; Rebecca Tirabassi; Jay A Nelson; Christopher A Ross; Yi Xing; Beverly L Davidson
Journal:  Neuron       Date:  2014-01-02       Impact factor: 17.173

2.  Stem cell transcriptome profiling via massive-scale mRNA sequencing.

Authors:  Nicole Cloonan; Alistair R R Forrest; Gabriel Kolle; Brooke B A Gardiner; Geoffrey J Faulkner; Mellissa K Brown; Darrin F Taylor; Anita L Steptoe; Shivangi Wani; Graeme Bethel; Alan J Robertson; Andrew C Perkins; Stephen J Bruce; Clarence C Lee; Swati S Ranade; Heather E Peckham; Jonathan M Manning; Kevin J McKernan; Sean M Grimmond
Journal:  Nat Methods       Date:  2008-05-30       Impact factor: 28.547

3.  Enhanced artemin/GFRα3 levels regulate mechanically insensitive, heat-sensitive C-fiber recruitment after axotomy and regeneration.

Authors:  Michael P Jankowski; Kristofer K Rau; Deepak J Soneji; Collene E Anderson; H Richard Koerber
Journal:  J Neurosci       Date:  2010-12-01       Impact factor: 6.167

4.  NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses.

Authors:  Konstantin D Taganov; Mark P Boldin; Kuang-Jung Chang; David Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-02       Impact factor: 11.205

5.  MiR-34a regulates therapy resistance by targeting HDAC1 and HDAC7 in breast cancer.

Authors:  Mei-Yi Wu; Junjiang Fu; Xiuli Xiao; Jingbo Wu; Ray-Chang Wu
Journal:  Cancer Lett       Date:  2014-08-27       Impact factor: 8.679

6.  miR-206 Expression is down-regulated in estrogen receptor alpha-positive human breast cancer.

Authors:  Naoto Kondo; Tatsuya Toyama; Hiroshi Sugiura; Yoshitaka Fujii; Hiroko Yamashita
Journal:  Cancer Res       Date:  2008-07-01       Impact factor: 12.701

7.  Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.

Authors:  Minoru Toyota; Hiromu Suzuki; Yasushi Sasaki; Reo Maruyama; Kohzoh Imai; Yasuhisa Shinomura; Takashi Tokino
Journal:  Cancer Res       Date:  2008-06-01       Impact factor: 12.701

8.  Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding.

Authors:  Aleksandra Helwak; Grzegorz Kudla; Tatiana Dudnakova; David Tollervey
Journal:  Cell       Date:  2013-04-25       Impact factor: 41.582

9.  MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma.

Authors:  Amanda Tivnan; Lorraine Tracey; Patrick G Buckley; Leah C Alcock; Andrew M Davidoff; Raymond L Stallings
Journal:  BMC Cancer       Date:  2011-01-25       Impact factor: 4.430

10.  Prognostic significance of the expression of GFRα1, GFRα3 and syndecan-3, proteins binding ARTEMIN, in mammary carcinoma.

Authors:  Zheng-Sheng Wu; Vijay Pandey; Wen-Yong Wu; Shan Ye; Tao Zhu; Peter E Lobie
Journal:  BMC Cancer       Date:  2013-01-26       Impact factor: 4.430

View more
  26 in total

1.  Ablation of miR-146b in mice causes hematopoietic malignancy.

Authors:  Takahiro Mitsumura; Yoshiaki Ito; Tomoki Chiba; Takahide Matsushima; Ryota Kurimoto; Yoko Tanaka; Tomomi Kato; Keisuke Uchida; Takashi Ito; Kouhei Yamamoto; Yoshinobu Eishi; Masanobu Kitagawa; Yasunari Miyazaki; Naohiko Inase; Hiroshi Asahara
Journal:  Blood Adv       Date:  2018-12-11

2.  The tRNA pseudouridine synthase TruB1 regulates the maturation of let-7 miRNA.

Authors:  Ryota Kurimoto; Tomoki Chiba; Yoshiaki Ito; Takahide Matsushima; Yuki Yano; Kohei Miyata; Yuka Yashiro; Tsutomu Suzuki; Kozo Tomita; Hiroshi Asahara
Journal:  EMBO J       Date:  2020-09-14       Impact factor: 11.598

3.  Comparing two approaches of miR-34a target identification, biotinylated-miRNA pulldown vs miRNA overexpression.

Authors:  Hassaan Mehboob Awan; Abdullah Shah; Farooq Rashid; Shuai Wei; Liang Chen; Ge Shan
Journal:  RNA Biol       Date:  2017-11-09       Impact factor: 4.652

4.  miR-34a induces immunosuppression in colorectal carcinoma through modulating a SIRT1/NF-κB/B7-H3/TNF-α axis.

Authors:  Fanyi Meng; Man Yang; Yinshuang Chen; Weichang Chen; Weipeng Wang
Journal:  Cancer Immunol Immunother       Date:  2021-01-25       Impact factor: 6.968

Review 5.  MicroRNA Targeting.

Authors:  Hossein Ghanbarian; Mehmet Taha Yıldız; Yusuf Tutar
Journal:  Methods Mol Biol       Date:  2022

Review 6.  Nanodiamonds and their potential applications in breast cancer therapy: a narrative review.

Authors:  Kenny Tjo; Pegah Varamini
Journal:  Drug Deliv Transl Res       Date:  2021-05-10       Impact factor: 4.617

7.  MicroRNA Expression Profiling, Target Identification, and Validation in Chondrocytes.

Authors:  Tomoki Chiba; Ryota Kurimoto; Takahide Matsushima; Yoshiaki Ito; Ryo Nakamichi; Martin Lotz; Hiroshi Asahara
Journal:  Methods Mol Biol       Date:  2021

8.  Could miR-34a Inhibition be Used as a Tool to Overcome Drug Resistance in MCF-7 Cells Treated with Synthesized Steroidal Heterocycles?

Authors:  Shaymaa M M Yahya; Mervat M Abd-Elhalim; Abdou O Abdelhamid; Emad F Eskander; Ghada H Elsayed
Journal:  Asian Pac J Cancer Prev       Date:  2021-03-01

9.  miR-452-5p regulates the responsiveness of intestinal epithelial cells in inflammatory bowel disease through Mcl-1.

Authors:  Ming Deng; Jianglin Hu; Rui Tong; Hongming Guo; Xuehui Li; Yan Liu
Journal:  Exp Ther Med       Date:  2021-05-28       Impact factor: 2.447

10.  Both microRNA-455-5p and -3p repress hypoxia-inducible factor-2α expression and coordinately regulate cartilage homeostasis.

Authors:  Yoshiaki Ito; Tokio Matsuzaki; Fumiaki Ayabe; Sho Mokuda; Ryota Kurimoto; Takahide Matsushima; Yusuke Tabata; Maiko Inotsume; Hiroki Tsutsumi; Lin Liu; Masahiro Shinohara; Yoko Tanaka; Ryo Nakamichi; Keiichiro Nishida; Martin K Lotz; Hiroshi Asahara
Journal:  Nat Commun       Date:  2021-07-06       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.